Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension
The International Journal of Cardiovascular Imaging · 2024
DOI: 10.1007/s10554-024-03119-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Cardiovascular Imaging, 2024. Verfasst von Tatsuya Nishii und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. ttsynishii@gmail.com. Hauptthemen laut MEDLINE: Predictive Value of Tests, Pulmonary Embolism, Hypertension, Pulmonary, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This study examines the hepatic extracellular volume fraction (ECV) disparity between the left and right lobes (ECV_left and ECV_right) in patients with chronic thromboembolic pulmonary hypertension (CTEPH), its association with right heart catheterization (RHC) metrics, and with intolerance to increased pulmonary hypertension (PH)-targeted medication dosages. METHODS: We retrospectively analyzed 72 CTEPH-diagnosed patients who underwent equilibrium-phase abdominal dual-energy CT (DECT) and RHC. Hepatic ECVs, derived from DECT's iodine maps using circular regions of interest in the liver and aorta, were correlated with RHC parameters via Spearman's rank correlation and lobe differences through the Wilcoxon signed-rank test. Logistic regression assessed cases with ECV_left exceeding ECV_right by > 0.05, while receiver operating characteristic curve analysis gauged ECVs' predictive power for medication intolerance. RESULTS: Of the 72 patients (57 females; median age 69), ECV_total (0.24, IQR 0.20-0.27) moderately correlated with RHC parameters (rs = 0.28, -0.24, 0.3 for mean pulmonary arterial pressure, cardiac index [CI], and pulmonary vascular resistance index, respectively). ECV_left significantly surpassed ECV_right (0.25 vs. 0.22, p 0.05 indicating notably lower CI (p < 0.001). In 27 patients on PH medication, ECV_left effectively predicted medication intolerance (AUC = 0.84). CONCLUSION: In CTEPH patients, hepatic ECV correlated with RHC metrics, where elevated left lobe ECV suggested reduced CI and potential medication intolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. ttsynishii@gmail.com.
- Department of Radiology, National Cerebral and Cardiovascular Center, 6-1, Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
- Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
- Department of Cardiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Zitieren
APA
Nishii, T., Horinouchi, H., Namboku, T., Sofue, K., Asano, R., Kotoku, A., Ohta, Y., Ogo, T., & Fukuda, T. (2024). Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-024-03119-6
Vancouver
Nishii T, Horinouchi H, Namboku T, Sofue K, Asano R, Kotoku A, et al. Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension. The International Journal of Cardiovascular Imaging. 2024. doi:10.1007/s10554-024-03119-6
BibTeX
@article{Nishii2024,
author = {Nishii, Tatsuya and Horinouchi, Hiroki and Namboku, Takara and Sofue, Keitaro and Asano, Ryotaro and Kotoku, Akiyuki and Ohta, Yasutoshi and Ogo, Takeshi and Fukuda, Tetsuya},
title = {Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension},
journal = {The International Journal of Cardiovascular Imaging},
year = {2024},
doi = {10.1007/s10554-024-03119-6}
}
EUVIMED